Key result
This review addresses controversies surrounding topical analgesia with TIVA, muscle relaxants, reversal agents, and monitoring standards for anesthesia in the Interventional Pulmonology Suite.
This review addresses controversies in anesthesia management for interventional pulmonology procedures, focusing on topical analgesia, muscle relaxants, and monitoring.
Alerts clinicians to unresolved anesthesia controversies in interventional pulmonology; leaves optimal protocols open for prospective trials.
The number of anesthetics for both simple diagnostic and complex therapeutic procedures being performed in non-operating room locations (NORA) in dedicated Interventional Pulmonology Suites have been increasing in the past few years. Anesthesiologists must be familiar with the demands necessitated by the procedures performed by the interventionists and tailor the anesthetic to create a still field while carefully considering the patient's altered pharmacokinetics and reduced cardio-pulmonary function and choose a technique that allows prompt recovery and early discharge in these patients, many of whom are elderly and frail. In this article we will address controversies surrounding the use of topical analgesia in patients already anesthetized by a TIVA technique and the questions of choice of muscle relaxants and reversal agents and standard of monitoring during these procedures.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2018) conducted a review in Anesthesia for procedures in the Interventional Pulmonology Suite. Anesthesia techniques (topical analgesia, TIVA, muscle relaxants, monitoring) was evaluated. This review addresses controversies surrounding topical analgesia with TIVA, muscle relaxants, reversal agents, and monitoring standards for anesthesia in the Interventional Pulmonology Suite.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: